Financiación
Investigador/a: Javier Gonzalez Vaz
3 financiaciones - 666.283€
2021
-
Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFb; antagonists in synergistic combined cancer
euro 459.800,00
-
Desarrolo preclínico y translacional de una estrategia inmunoterapia intratumoral consitente en la combinacion de BO-112 STING
euro 126.500,00
-
CANCER ORGANOIDS COCULTURED WITH T CELLS AND FIBROBLASTS AS A NEW TOOL TO TEST AND
BENCHMARK IMMUNOTHERAPY STRATEGIES
euro 79.983,00